Serious thought processes going on here. The conundrum is regarding funding:
Do I sell 2500 shares of South32, which is an ASX20 (close enough), dividend paying, high capital growth prospect (past and current) in order to raise the approx $10K to fund a penny stock that has yet to prove anything, has changed its pathways several times in the past decade or so, and whose management has only recently found the light and is gearing up for potentially a financially viable project that may or may not produce sufficient capital growth or a dividend
See my problem?
Welcome to speccy stocks
- Forums
- ASX - By Stock
- KRR
- Ann: Half Year Accounts
Ann: Half Year Accounts, page-22
Featured News
Add KRR (ASX) to my watchlist
(20min delay)
|
|||||
Last
1.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $15.28M |
Open | High | Low | Value | Volume |
1.0¢ | 1.0¢ | 1.0¢ | $1.344K | 134.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
20 | 5017473 | 0.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.0¢ | 364827 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
20 | 5017473 | 0.009 |
21 | 27795039 | 0.008 |
5 | 3681378 | 0.007 |
8 | 8989696 | 0.006 |
12 | 8038888 | 0.005 |
Price($) | Vol. | No. |
---|---|---|
0.010 | 364827 | 4 |
0.011 | 3549692 | 6 |
0.012 | 1814039 | 8 |
0.013 | 2233363 | 5 |
0.014 | 1486416 | 5 |
Last trade - 16.10pm 13/11/2024 (20 minute delay) ? |
Featured News
KRR (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online